{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:53:42Z","timestamp":1775620422946,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12094-015-1375-y","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T07:43:06Z","timestamp":1441093386000},"page":"375-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer"],"prefix":"10.1007","volume":"18","author":[{"given":"W.-G.","family":"Lan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.-Z.","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.-H.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.-L.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.-B.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"1375_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7314\/APJCP.2015.16.1.321","volume":"16","author":"C Ordu","year":"2015","unstructured":"Ordu C, Selcuk NA, Akosman C, Eren OO, Altunok EC, Toklu T, et al. Comparison of metabolic and anatomic response to chemotherapy based on PERCIST and RECIST in patients with advanced stage non-small cell lung cancer. Asian Pac J Cancer Prev. 2015;16:321\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1375_CR2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.rmed.2007.09.009","volume":"102","author":"S Semrau","year":"2008","unstructured":"Semrau S, Klautke G, Virchow JC, Kundt G, Fietkau R. Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy. Respir Med. 2008;102:210\u20138.","journal-title":"Respir Med"},{"key":"1375_CR3","first-page":"85","volume":"83","author":"V Ratanatharathorn","year":"2000","unstructured":"Ratanatharathorn V, Lorvidhaya V, Kraipiboon P, Sirachainan E, Maoleekoonpairoj S, Phromratanapongse P, et al. Phase II study of concurrent chemoradiotherapy for inoperable (bulky) stage III (A\/B) non-small cell lung cancer (NSCLC): a preliminary report. J Med Assoc Thai. 2000;83:85\u201392.","journal-title":"J Med Assoc Thai"},{"key":"1375_CR4","doi-asserted-by":"crossref","first-page":"266S","DOI":"10.1378\/chest.07-1380","volume":"132","author":"JR Jett","year":"2007","unstructured":"Jett JR, Schild SE, Keith RL, Kesler KA. American College of Chest P: treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:266S\u201376S.","journal-title":"Chest"},{"issue":"Suppl 2","key":"1375_CR5","first-page":"11","volume":"50","author":"V Manolov","year":"2011","unstructured":"Manolov V, Marinov B, Vasilev V, Andreeva A. HE4\u2014a new tumor marker for ovarian cancer. Akush Ginekol (Sofiia). 2011;50(Suppl 2):11\u20135.","journal-title":"Akush Ginekol (Sofiia)"},{"key":"1375_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-387042-1.00001-0","volume":"55","author":"M Montagnana","year":"2011","unstructured":"Montagnana M, Danese E, Giudici S, Franchi M, Guidi GC, Plebani M, et al. HE4 in ovarian cancer: from discovery to clinical application. Adv Clin Chem. 2011;55:1\u201320.","journal-title":"Adv Clin Chem"},{"key":"1375_CR7","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1007\/s13277-014-1943-8","volume":"35","author":"X Wang","year":"2014","unstructured":"Wang X, Fan Y, Wang J, Wang H, Liu W. Evaluating the expression and diagnostic value of human epididymis protein 4 (HE4) in small cell lung cancer. Tumour Biol. 2014;35:6847\u201353.","journal-title":"Tumour Biol"},{"key":"1375_CR8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2014.12.037","volume":"136","author":"A Stiekema","year":"2015","unstructured":"Stiekema A, Boldingh QJ, Korse CM, van der Noort V, Boot H, van Driel WJ, et al. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin. Gynecol Oncol. 2015;136:562\u20136.","journal-title":"Gynecol Oncol"},{"key":"1375_CR9","first-page":"1639","volume":"52","author":"B Nagy Jr","year":"2014","unstructured":"Nagy B Jr, Bhattoa HP, Steiber Z, Csoban M, Szilasi M, Mehes G, et al. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer. Clin Chem Lab Med. 2014;52:1639\u201348.","journal-title":"Clin Chem Lab Med"},{"key":"1375_CR10","doi-asserted-by":"crossref","first-page":"e0128836","DOI":"10.1371\/journal.pone.0128836","volume":"10","author":"PJ Lamy","year":"2015","unstructured":"Lamy PJ, Plassot C, Pujol JL. Serum HE4: an independent prognostic factor in non-small cell lung cancer. PLoS One. 2015;10:e0128836.","journal-title":"PLoS One"},{"key":"1375_CR11","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1515\/cclm-2012-0097","volume":"50","author":"L Hertlein","year":"2012","unstructured":"Hertlein L, Stieber P, Kirschenhofer A, Krocker K, Nagel D, Lenhard M, et al. Human epididymis protein 4 (HE4) in benign and malignant diseases. Clin Chem Lab Med. 2012;50:2181\u20138.","journal-title":"Clin Chem Lab Med"},{"key":"1375_CR12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cam4.428","volume":"4","author":"JE Choi","year":"2015","unstructured":"Choi JE, Villarreal J, Lasala J, Gottumukkala V, Mehran RJ, Rice D, et al. Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study. Cancer Med. 2015;4:825\u201333.","journal-title":"Cancer Med"},{"key":"1375_CR13","first-page":"5568","volume":"7","author":"Y Jiang","year":"2014","unstructured":"Jiang Y, Wang C, Lv B, Ma G, Wang L. Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer. Int J Clin Exp Med. 2014;7:5568\u201372.","journal-title":"Int J Clin Exp Med"},{"key":"1375_CR14","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.5588\/ijtld.13.0058","volume":"17","author":"W Liu","year":"2013","unstructured":"Liu W, Yang J, Chi PD, Zheng X, Dai SQ, Chen H, et al. Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis. Int J Tuberc Lung Dis. 2013;17:1346\u201353.","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1375-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-015-1375-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1375-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:51:46Z","timestamp":1559447506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-015-1375-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1375"],"URL":"https:\/\/doi.org\/10.1007\/s12094-015-1375-y","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}